Literature DB >> 8212203

Parvovirus B19 infection in pediatric transplant patients.

B Nour1, M Green, M Michaels, J Reyes, A Tzakis, J C Gartner, L McLoughlin, T E Starzl.   

Abstract

Evidence of recent parvovirus virus infection (as determined by the presence of a positive IgM antibody titer) without other identified causes of anemia was found in 5 of 26 pediatric solid-organ transplant recipients evaluated for moderate-to-severe anemia between June 1990 and July 1991. Anemia tended to be chronic (median duration of anemia at the time of diagnosis was 12 weeks) and was associated with normal red blood cell indices in the absence of reticulocytes. The median age of the children at the time of presentation with anemia due to parvovirus was 1.8 years at a median time of 8 months after transplantation. Four of the 5 children were treated with i.v. immunoglobulin because of persistence of anemia requiring blood transfusions. A response characterized by an increase in reticulocyte count and normalization of hemoglobin was seen in each of these patients 2-4 weeks after treatment. The remaining patient experienced a spontaneous recovery from her anemia. Parvovirus infection should be included in the differential diagnosis of solid-organ transplant recipients presenting with severe anemia associated with low or absent reticulocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212203      PMCID: PMC2978663          DOI: 10.1097/00007890-199310000-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  25 in total

1.  Human parvovirus B19.

Authors:  L J Anderson; T J Török
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

2.  Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.

Authors:  G Kurtzman; N Frickhofen; J Kimball; D W Jenkins; A W Nienhuis; N S Young
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

3.  Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient.

Authors:  H T Weiland; M M Salimans; W E Fibbe; P M Kluin; B J Cohen
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

Review 4.  Diseases caused by the human parvovirus B19.

Authors:  J R Pattison
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

5.  Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.

Authors:  W C Koch; G Massey; C E Russell; S P Adler
Journal:  J Pediatr       Date:  1990-03       Impact factor: 4.406

6.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 7.  Human parvoviruses.

Authors:  L J Anderson
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

Review 8.  Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission.

Authors:  S P Rao; S T Miller; B J Cohen
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

9.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease.

Authors:  J L Graeve; P A de Alarcon; S J Naides
Journal:  Am J Pediatr Hematol Oncol       Date:  1989
View more
  11 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Parvovirus B19 in anemic liver transplant recipients.

Authors:  O K Ndimbie; E Frezza; J A Jordan; W Koch; D H van Thiel
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

Review 5.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 6.  Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Authors:  Ting-Bo Liang; Dong-Lin Li; Jun Yu; Xue-Li Bai; Liang Liang; Shi-Guo Xu; Wei-Lin Wang; Yan Shen; Min Zhang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

7.  Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.

Authors:  Shigeki Ito; Tatsuo Oyake; Toshiyuki Uchiyama; Takeshi Sugawara; Kazunori Murai; Yoji Ishida
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

8.  Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.

Authors:  Michael Würdinger; Susanne Modrow; Annelie Plentz
Journal:  Viruses       Date:  2017-06-13       Impact factor: 5.048

Review 9.  Parvovirus B19-induced severe anemia in heart transplant recipients: Case report and review of the literature.

Authors:  Natalia C Pinto; Clarissa Newman; Carlos A Gomez; Kiran K Khush; Yasbanoo Moayedi; Roy Lee; Jeffrey J Teuteberg; Jose G Montoya
Journal:  Clin Transplant       Date:  2019-03-07       Impact factor: 2.863

10.  RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.

Authors:  Jianke Wang; Safder S Ganaie; Fang Cheng; Peng Xu; Kang Ning; Xiaomei Wang; Steve Kleiboeker; Shipeng Cheng; Jianming Qiu
Journal:  mBio       Date:  2020-03-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.